• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对CCN4、血管细胞黏附分子-1(VCAM-1)、基质金属蛋白酶-3(MMP-3)和粒细胞-巨噬细胞集落刺激因子(GM-CSF)作为类风湿性关节炎疾病活动可靠标志物的广泛研究。

Extensive study of CCN4, VCAM-1, MMP-3, and GM-CSF as reliable markers for disease activity in rheumatoid arthritis.

作者信息

Yasin Ahmed T, Ali Eman T, Shari Falah H, Mohammed Ali N

机构信息

Basrah Hospital for Women and Children, Pharmacy Department, Basrah Health Directorate, Basrah, Iraq.

Department of Clinical Laboratory Sciences, College of Pharmacy, University of Basrah, Basrah, Iraq.

出版信息

J Taibah Univ Med Sci. 2024 Aug 13;19(4):885-900. doi: 10.1016/j.jtumed.2024.08.001. eCollection 2024 Aug.

DOI:10.1016/j.jtumed.2024.08.001
PMID:39262670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11387248/
Abstract

BACKGROUND

The involvement of Wnt-1-induced secreted protein-1 (WISP1/CCN4) in several inflammatory reaction has recently been proposed. Nevertheless, this protein's involvement in rheumatoid arthritis (RA) remains debated. Associations between poorly diagnosed RA and several classical markers derived from demography and biochemistry have been reported.

AIM

We sought to investigate the reliability and effectiveness of serum concentrations of CCN4, vascular cell adhesion molecule-1 (VCAM-1), matrix melloprotenase-3 (MMP-3), and granulocyte-macrophage colony-stimulating factor (GM-CSF) in monitoring and predicting RA and bone damage, and their correlation with RA disease course.

METHODS

The study analyzed 128 patients with RA, comprising 68 newly diagnosed and 60 previously diagnosed patients, as well as 60 controls. Biomarker levels were measured with enzyme linked immuno-sorbent assays. Routine laboratory parameters such as serological, clinical, biochemical, and hematological parameters were additionally measured. Demography, anthropometry, and clinical symptom data were collected through interviews and a questionnaire. The joint disease activity score 28 (DAS28) was used to determine disease activity.

RESULTS

Concentrations of four biomarkers were significantly higher in the RA group than the healthy controls. Elevated biomarker concentrations were also observed in patients with high, rather than moderate or low, DAS28-ESR activity status, except for monocyte count, hematocrit (%), and urea level. Furthermore, CCN4 level positively correlated with VCAM-1, MMP-3, and GM-CSF levels, DA-S28-CRP and DAS28-ESR. The levels of three predictive markers, CCN4, VCAM-1, and MMP-3, were elevated in non-treated patients, whereas GM-CSF level showed no difference. The highest area under the curve was 73.3% for CCN4, with 93.3% sensitivity and 64.7% specificity.

CONCLUSION

Our data suggest that CCN4 can be reliably used to indicate activity and therapeutic response associated with RA, thus facilitating earlier RA diagnosis.

摘要

背景

最近有人提出Wnt-1诱导分泌蛋白-1(WISP1/CCN4)参与多种炎症反应。然而,这种蛋白在类风湿关节炎(RA)中的作用仍存在争议。已有报道称,诊断不明确的RA与一些源自人口统计学和生物化学的经典标志物之间存在关联。

目的

我们试图研究血清中CCN4、血管细胞黏附分子-1(VCAM-1)、基质金属蛋白酶-3(MMP-3)和粒细胞-巨噬细胞集落刺激因子(GM-CSF)的浓度在监测和预测RA及骨损伤方面的可靠性和有效性,以及它们与RA病程的相关性。

方法

该研究分析了128例RA患者,包括68例新诊断患者和60例既往诊断患者,以及60例对照。采用酶联免疫吸附测定法测量生物标志物水平。另外还测量了常规实验室参数,如血清学、临床、生化和血液学参数。通过访谈和问卷收集人口统计学、人体测量学和临床症状数据。采用28个关节疾病活动评分(DAS28)来确定疾病活动度。

结果

RA组中四种生物标志物的浓度显著高于健康对照组。除单核细胞计数、血细胞比容(%)和尿素水平外,在DAS28-ESR活动度高而非中度或低度的患者中也观察到生物标志物浓度升高。此外,CCN4水平与VCAM-1、MMP-3和GM-CSF水平、DA-S28-CRP和DAS28-ESR呈正相关。三种预测标志物CCN4、VCAM-1和MMP-3的水平在未治疗患者中升高,而GM-CSF水平无差异。CCN4的曲线下面积最高,为73.3%,敏感性为93.3%,特异性为64.7%。

结论

我们的数据表明,CCN4可可靠地用于指示与RA相关的活动度和治疗反应,从而有助于早期RA诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b200/11387248/06ed74a259cd/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b200/11387248/64c79314bbed/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b200/11387248/95f9da680b6d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b200/11387248/5a1e8bce0362/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b200/11387248/06ed74a259cd/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b200/11387248/64c79314bbed/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b200/11387248/95f9da680b6d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b200/11387248/5a1e8bce0362/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b200/11387248/06ed74a259cd/gr4.jpg

相似文献

1
Extensive study of CCN4, VCAM-1, MMP-3, and GM-CSF as reliable markers for disease activity in rheumatoid arthritis.对CCN4、血管细胞黏附分子-1(VCAM-1)、基质金属蛋白酶-3(MMP-3)和粒细胞-巨噬细胞集落刺激因子(GM-CSF)作为类风湿性关节炎疾病活动可靠标志物的广泛研究。
J Taibah Univ Med Sci. 2024 Aug 13;19(4):885-900. doi: 10.1016/j.jtumed.2024.08.001. eCollection 2024 Aug.
2
Serum GM-CSF level is a predictor of treatment response to tocilizumab in rheumatoid arthritis patients: a prospective observational cohort study.血清 GM-CSF 水平是类风湿关节炎患者托珠单抗治疗反应的预测因子:一项前瞻性观察队列研究。
Arthritis Res Ther. 2024 Jul 12;26(1):130. doi: 10.1186/s13075-024-03373-y.
3
Matrix metalloproteinase-3 levels in relation to disease activity and radiological progression in rheumatoid arthritis.基质金属蛋白酶-3 水平与类风湿关节炎的疾病活动和放射学进展的关系。
Adv Clin Exp Med. 2019 May;28(5):665-670. doi: 10.17219/acem/94065.
4
Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.风湿性疾病中基质金属蛋白酶MMP - 3和MMP - 1、金属蛋白酶组织抑制剂1(TIMP - 1)以及MMP - 1/TIMP - 1复合物的循环水平。与类风湿关节炎临床活动度及其他替代标志物的相关性。
J Rheumatol. 1999 Feb;26(2):251-8.
5
Semi-quantitative analysis of F fluorodeoxyglucose uptake in the assessment of disease activity and therapeutic response in rheumatoid arthritis: An institutional experience.类风湿关节炎疾病活动度及治疗反应评估中¹⁸F-氟脱氧葡萄糖摄取的半定量分析:一项机构经验
World J Nucl Med. 2020 Jun 27;19(4):347-352. doi: 10.4103/wjnm.WJNM_12_20. eCollection 2020 Oct-Dec.
6
Cell adhesion molecules and plasminogen activator inhibitor type-1 (PAI-1) in patients with rheumatoid arthritis: influence of metabolic syndrome.类风湿关节炎患者的细胞黏附分子和纤溶酶原激活物抑制剂-1(PAI-1):代谢综合征的影响。
Clin Exp Med. 2018 Nov;18(4):495-504. doi: 10.1007/s10238-018-0516-3. Epub 2018 Jul 14.
7
Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial.纳武利尤单抗,一种针对粒细胞-巨噬细胞集落刺激因子(GM-CSF)配体的人源单克隆抗体,在对背景甲氨蝶呤治疗反应不足或对 TNF(肿瘤坏死因子)生物治疗反应不足或不耐受的类风湿关节炎(RA)患者中的疗效和安全性:一项随机对照试验。
Arthritis Res Ther. 2019 Apr 18;21(1):101. doi: 10.1186/s13075-019-1879-x.
8
GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis.未分化关节炎患者关节中GM-CSF表达及巨噬细胞极化情况:向类风湿关节炎或银屑病关节炎演变的过程
Front Immunol. 2021 Feb 17;11:613975. doi: 10.3389/fimmu.2020.613975. eCollection 2020.
9
[Diagnostic Value of Interleukin 6, Interleukin 12P70, Serum Amyloid A, and Procalcitonin for Rheumatoid Arthritis and Their Relationship With the Disease Activity].[白细胞介素6、白细胞介素12P70、血清淀粉样蛋白A及降钙素原对类风湿关节炎的诊断价值及其与疾病活动度的关系]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Jul 20;55(4):995-1000. doi: 10.12182/20240760107.
10
Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients.基质金属蛋白酶-3的基线血清水平作为类风湿关节炎患者关节进行性损伤的生物标志物。
Int J Rheum Dis. 2016 Apr;19(4):377-84. doi: 10.1111/1756-185X.12434. Epub 2014 Oct 7.

本文引用的文献

1
Serum matrix metalloproteinase-3 levels monitor the therapeutic efficacy in Syrian patients with rheumatoid arthritis.血清基质金属蛋白酶-3水平可监测叙利亚类风湿关节炎患者的治疗效果。
Heliyon. 2023 Feb 24;9(3):e14008. doi: 10.1016/j.heliyon.2023.e14008. eCollection 2023 Mar.
2
Elevated VCAM-1, MCP-1 and ADMA serum levels related to pulmonary fibrosis of interstitial lung disease associated with rheumatoid arthritis.血管细胞黏附分子-1、单核细胞趋化蛋白-1及不对称二甲基精氨酸血清水平升高与类风湿关节炎相关间质性肺疾病的肺纤维化有关。
Front Mol Biosci. 2022 Dec 19;9:1056121. doi: 10.3389/fmolb.2022.1056121. eCollection 2022.
3
The diagnostic utility of rheumatoid factor and anticitrullinated protein antibody for rheumatoid arthritis in the Indian population.
类风湿因子和抗瓜氨酸化蛋白抗体在印度人群中对类风湿关节炎的诊断效用。
Med J Armed Forces India. 2022 Sep;78(Suppl 1):S69-S74. doi: 10.1016/j.mjafi.2020.04.007. Epub 2020 Jul 17.
4
Vascular cell adhesion molecule-1 in rheumatoid arthritis patients: Relation to disease activity, oxidative stress, and systemic inflammation.类风湿关节炎患者的血管细胞黏附分子-1:与疾病活动度、氧化应激和全身炎症的关系。
Saudi Med J. 2021 Jun;42(6):620-628. doi: 10.15537/smj.2021.42.6.20200753.
5
Targeting CCN Proteins in Rheumatoid Arthritis and Osteoarthritis.靶向类风湿关节炎和骨关节炎中的 CCN 蛋白。
Int J Mol Sci. 2021 Apr 21;22(9):4340. doi: 10.3390/ijms22094340.
6
Biomarkers associated with cardiovascular disease in patients with early rheumatoid arthritis.与早期类风湿关节炎患者心血管疾病相关的生物标志物。
PLoS One. 2019 Aug 5;14(8):e0220531. doi: 10.1371/journal.pone.0220531. eCollection 2019.
7
MMP3 is a reliable marker for disease activity, radiological monitoring, disease outcome predictability, and therapeutic response in rheumatoid arthritis.MMP3 是类风湿关节炎疾病活动、影像学监测、疾病预后预测和治疗反应的可靠标志物。
Best Pract Res Clin Rheumatol. 2018 Aug;32(4):550-562. doi: 10.1016/j.berh.2019.01.006. Epub 2019 Feb 14.
8
A Comparative Study of Interleukin 6, Inflammatory Markers, Ferritin, and Hematological Profile in Rheumatoid Arthritis Patients with Anemia of Chronic Disease and Iron Deficiency Anemia.类风湿关节炎合并慢性病贫血和缺铁性贫血患者中白细胞介素6、炎症标志物、铁蛋白及血液学指标的比较研究
Anemia. 2019 Apr 1;2019:3457347. doi: 10.1155/2019/3457347. eCollection 2019.
9
Diagnosis and Management of Rheumatoid Arthritis: A Review.类风湿关节炎的诊断与治疗:综述。
JAMA. 2018 Oct 2;320(13):1360-1372. doi: 10.1001/jama.2018.13103.
10
Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment.多生物标志物疾病活动评分预测停止 TNF 抑制剂治疗的类风湿关节炎患者疾病复发。
PLoS One. 2018 May 23;13(5):e0192425. doi: 10.1371/journal.pone.0192425. eCollection 2018.